$OSCR Balance Sheet | Understand Stock

$OSCR

$31.35 +$0.25 (0.8%) Close

$OSCR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current Assets:
Cash and cash equivalents
Short-term investments
Premiums and accounts receivable (net of allowance for credit losses of $7,226 and $31,300)
Risk adjustment transfer receivable
Accrued investment income
Accounts receivable (net of allowance for credit losses of $55,298 and $7,226)
Reinsurance recoverable
Receivables from CMS
Other current assets
Total current assets
Long-term investments
Property, equipment, and capitalized software, net
Restricted deposits
Other assets
Net deferred tax asset
Total assets

Liabilities and Stockholders' Equity
Current Liabilities:
Payables to CMS
Benefits payable
Risk adjustment transfer payable
Premium deficiency reserve
Accounts payable and other liabilities
Unearned premiums
Reinsurance payable
Total current liabilities
Long-term debt
Warrant liabilities
Other liabilities
Total liabilities
Convertible Preferred Stock, $0.00001 par value; 407,156,831 shares authorized; 400,904,302 shares issued and outstanding as of December 31, 2020
Stockholders' Equity
Preferred stock, $0.00001 par value; 82,500,000 shares authorized, none outstanding as of September 30, 2023 and December 31, 2022
Common stock
Common Class A
Common Class B
Treasury stock (315 thousand shares as of June 30, 2026 and December 31, 2025)
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Total Oscar Health, Inc. stockholders' equity
Noncontrolling interests
Total stockholders' equity
Total liabilities and stockholders' equity

Preferred stock, shares authorized
Treasury stock (in shares)
Common stock, shares outstanding (in shares)
Common Class A
Common Class B

Comments